Funding agencies: This study was supported by a grant from the German Ministry of Education and Research (Competence Network Parkinson syndromes; no. 01GI9901/1).
Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease
Article first published online: 10 APR 2013
Copyright © 2013 Movement Disorder Society
Volume 28, Issue 6, pages 763–771, June 2013
How to Cite
Dams, J., Siebert, U., Bornschein, B., Volkmann, J., Deuschl, G., Oertel, W. H., Dodel, R. and Reese, J.-P. (2013), Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease. Mov. Disord., 28: 763–771. doi: 10.1002/mds.25407
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 25 JUN 2013
- Article first published online: 10 APR 2013
- Manuscript Accepted: 26 DEC 2012
- Manuscript Revised: 9 NOV 2012
- Manuscript Received: 14 MAY 2012
This article has been cited by:
- 1Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson’s disease in the UK and Germany, Journal of Medical Economics, 2015, 18, 2, 155, ,
- 4Advances in Deep Brain Stimulation for Parkinson Disease: Early and “Asleep”?, World Neurosurgery, 2014, 81, 1, 6,
- 6Cost-Effectiveness of Subthalmic Nucleus Deep Brain Stimulation for the Treatment of Advanced Parkinson Disease in Hong Kong: A Prospective Study, World Neurosurgery, 2014, 82, 6, 987, , , , , , , , , , , ,
- 7Deep Brain Stimulation for Movement Disorders, Neurotherapeutics, 2014, 11, 3, 465,
- 9The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease, Journal of Neurology, 2014, 261, 1, 106, , , , , ,
- 10DBS a cost-effective option for PD in Germany, PharmacoEconomics & Outcomes News, 2013, 677, 1, 5